Our CEO Konstantinos Antonopoulos presented mk2 Biotechnologies on this year's ChemSpec Europe in Basel to the wider fine and specialty chemistry audience. The response to our alternative options to conventional active chemicals was significant and stimulated several fruitful discussions. Support and photographic material by BCNP Consultants is acknowledged.
mk2 Biotechnologies was awarded on two consecutive evenings for its Business Plan independently by the Science4Life initiative and BayStartUp, the Bavarian startup institution for company formation, financing and acceleration. We appreciate the awards and thank the jury members for their valuable feedback.
mk2 Biotechnologies is attending the 3rd European Chemistry Partnering in Frankfurt on February 26th 2019. We are looking forward to fruitful discussions. Come meet us and get an impression of our company, technology and product offer. Read more..